Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Other Operating Expenses (2016 - 2023)

Acro Biomedical has reported Other Operating Expenses over the past 2 years, most recently at $492000.0 for Q3 2023.

  • Quarterly results put Other Operating Expenses at $492000.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was $492000.0 (changed N/A YoY), and the annual figure for FY2023 was $492000.0, changed.
  • Other Operating Expenses for Q3 2023 was $492000.0 at Acro Biomedical, up from $7351.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for ACBM hit a ceiling of $492000.0 in Q3 2023 and a floor of $492000.0 in Q3 2023.